Author:
Aly Saida Abdel Regal,Hossain Murad,Bhuiyan Mohiuddin Ahmed,Nakamura Takashi,Nagatomo Takafumi
Publisher
Japanese Pharmacological Society
Subject
Pharmacology,Molecular Medicine
Reference31 articles.
1. 1 Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease ditection, awareness and treatment in primary care. JAMA. 2001;286:1317–1324.
2. 2 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S1–S75.
3. 3 Dormandy JA, Eutherford RB. Management of peripheral arterial diease (PAD). TASC Working Group. Trans Atalntic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1–S296.
4. 4 Furukawa K, Tanabe T, Hoshino S, Mishima Y, Matsuo H, Ota T, et al. [Therapeutic effects of sarpogrelate hydrochloride (MCI-9042) on chronic arterial occlusive disease: a double-blind comparison with ticlopidine hydrochloride.] Jpn J Clin Pharmacol Ther. 1991;7:1747–1770. (in Japanese)
5. 5 Hara H, Osakabe M, Kitajma A, Tamao Y, Kikumoto R. MCI-9042, a new antiplatelet agent is selective S2-serotonergic receptor antagonist. Thromb Haemost. 1991;65:415–420.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献